{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:27:57Z","timestamp":1763036877823},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2015,2,17]],"date-time":"2015-02-17T00:00:00Z","timestamp":1424131200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol Suppl"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s11789-015-0070-4","type":"journal-article","created":{"date-parts":[[2015,2,17]],"date-time":"2015-02-17T05:55:13Z","timestamp":1424152513000},"page":"2-7","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Indications for apheresis as an ultima ratio treatment of refractory hyperlipidemias"],"prefix":"10.1007","volume":"10","author":[{"given":"P.","family":"Gr\u00fctzmacher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Kleinert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Dorbath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"\u00d6hm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,2,17]]},"reference":[{"key":"70_CR1","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1093\/eurheartj\/ehu274","volume":"35","author":"M Cuchel","year":"2014","unstructured":"Cuchel M, Bruckert E, Ginsberg H et al (2014) Homozygous familial hypercholesterolaemia: new insight and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society. Eur Heart J 35:2146\u20132157","journal-title":"Eur Heart J"},{"key":"70_CR2","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1161\/CIRCULATIONAHA.111.042523","volume":"124","author":"FJ Raal","year":"2011","unstructured":"Raal FJ, Pilcher GJ, Panz VR, van Deventer HE, Brice BC, Blom DJ, Marais D (2011) Reduction in mortality in subjects with homozygous familial hypercholesterolemia associated with advances in lipid-lowering therapy. Circulation 124:2202\u20132207","journal-title":"Circulation"},{"key":"70_CR3","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.atherosclerosis.2012.02.019","volume":"223","author":"FJ Raal","year":"2012","unstructured":"Raal FJ, Santos RD (2012) Homozygous familial hypercholesterolemia: current perspectives on diagnosis and treatment. Atherosclerosis 223:262\u2013268","journal-title":"Atherosclerosis"},{"key":"70_CR4","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","volume":"32","author":"Z Reiner","year":"2011","unstructured":"Reiner Z et al (2011) ESC\/EAS guidelines for the management of dyslipidaemia of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 32:1769\u20131818","journal-title":"Eur Heart J"},{"key":"70_CR5","unstructured":"Robinson J et al (2014) Odyssey long-term and outcome study, Hotline session 707, ESC Congr. 2014, Barcelona, Spain"},{"key":"70_CR6","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(10)60284-X","volume":"375","author":"FJ Raal","year":"2010","unstructured":"Raal FJ, Santos RD, Blom DJ et al (2010) Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial. Lancet 375:998\u20131006","journal-title":"Lancet"},{"key":"70_CR7","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1056\/NEJMoa061189","volume":"356","author":"M Cuchel","year":"2007","unstructured":"Cuchel M, Bloedon LT, Szapary PO, Kolansky DM et al (2007) Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia. N Engl J Med 356:148\u2013156","journal-title":"N Engl J Med"},{"key":"70_CR8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(12)61731-0","volume":"381","author":"M Cuchel","year":"2013","unstructured":"Cuchel M, Meagher E, du Toit Theron H et al (2013) Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study. Lancet 381:40\u201346","journal-title":"Lancet"},{"key":"70_CR9","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1161\/ATVBAHA.107.160408","volume":"28","author":"Z Awan","year":"2008","unstructured":"Awan Z, Alrasadi K, Francis GA (2008) Vascular calcifications in homozygous familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 28:777\u2013785","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"45","key":"70_CR10","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","volume":"34","author":"BG Nordestgaard","year":"2013","unstructured":"Nordestgaard BG, Chapman MJ, Humphries SE, Ginsberg HN, Masana L, Descamps OS, Wiklund O, Hegele RA, Raal FJ, Defesche JC, Wiegman A, Santos RD, Watts GF, Parhofer KG et al (2013) Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease. Eur Heart J 34(45):3478\u20133490","journal-title":"Eur Heart J"},{"key":"70_CR11","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.4065\/76.10.1039","volume":"76","author":"A Vella","year":"2001","unstructured":"Vella A, Pineda AA, O\u2019Brien T (2001) Low-density lipoprotein apheresis for the treatment of refractory hyperlipidemia. Mayo Clin Proc 76:1039\u20131046","journal-title":"Mayo Clin Proc"},{"key":"70_CR12","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/MOL.0b013e3283402f53","volume":"21","author":"GR Thompson","year":"2010","unstructured":"Thompson GR, Catapano A, Saheb S, Atassi-Dumont M et al (2010) Severe hypercholesterolemia: therapeutic goals and eligibility criteria for LDL apheresis in Europe. Curr Opin Lipidol 21:492\u2013498","journal-title":"Curr Opin Lipidol"},{"key":"70_CR13","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2009.801","volume":"301","author":"PR Kamstrup","year":"2009","unstructured":"Kamstrup PR, Tybjaerg-Hansen A, Steffensen A, Nordestgaard BG (2009) Genetically elevated lipoprotein (a) and increased risk of myocardial infarction. JAMA 301:2331\u20132339","journal-title":"JAMA"},{"key":"70_CR14","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1161\/CIRCULATIONAHA.107.715698","volume":"117","author":"P Kamstrup","year":"2008","unstructured":"Kamstrup P, Benn M, Hansen A et al (2008) Extreme lipoprotein (a) levels and risk of myocardial Infarction in the general population, the Copenhagen City Heart Study. Circulation 117:176\u2013184","journal-title":"Circulation"},{"key":"70_CR15","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1056\/NEJMoa1201832","volume":"367","author":"EM Roth","year":"2013","unstructured":"Roth EM, Mc Kenney JM, Pharm D, Hanotin C, Asset G, Stein EA (2013) Atorvastatin with or without an antibody to PCSK9 in primary hypercholesterolemia. N Engl J Med 367:1891\u20131900","journal-title":"N Engl J Med"},{"key":"70_CR16","first-page":"228","volume":"6","author":"B J\u00e4ger","year":"2009","unstructured":"J\u00e4ger B, Richter Y, Nagel D et al (2009) Longitudinal cohort study of the effectiveness of lipid apheresis treatment to reduce high lipoprotein (a) levels and prevent major adverse coronary events. Nat Clin Pract Cardiovasc Med 6:228\u2013237","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"70_CR17","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1161\/CIRCULATIONAHA.113.002432","volume":"128","author":"J Leebmann","year":"2013","unstructured":"Leebmann J, Roseler E, Julius U et al (2013) Lipoprotein apheresis in patients of maximally tolerated lipid lowering therapy, Lp (a)-hyperlipoproteinemia an progressive cardiovascular disease: prospective observational multicenter study. Circulation 128:2567\u20132576","journal-title":"Circulation"},{"key":"70_CR18","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/00006676-199607000-00013","volume":"13","author":"A Piolot","year":"1996","unstructured":"Piolot A, Nadler F, Cavallero E, Coquard JL, Jacotot B (1996) Prevention of recurrent acute pancreatitis in patients with severe hypertriglyceridemia: value of regular plasmapheresis. Pancreas 13:96\u201399","journal-title":"Pancreas"},{"key":"70_CR19","doi-asserted-by":"crossref","unstructured":"Ewald N, Kloer HU (2009) Severe hypertriglyceridemia: An indication for apheresis? Atherosclerosis Suppl. 10: 49\u201352","DOI":"10.1016\/S1567-5688(09)71810-0"},{"key":"70_CR20","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/gt.2012.43","volume":"20","author":"D Gaudet","year":"2013","unstructured":"Gaudet D, M\u00e9thot J, D\u00e9ry S et al (2013) Efficacy and long-term safety of alipogene liparvovec (AAV1-LPLS 447X) gene therapy for lipoprotein lipase deficiency: an open label trial. Gene Ther 20:361\u2013369","journal-title":"Gene Ther"},{"key":"70_CR21","unstructured":"Schettler G, M\u00fcnnich S (1998) Lipidosen oder Lipidspeicherkrankheiten. In: Schwandt P, Richter WO (Hrsg) Handbuch der Fettstoffwechselst\u00f6rungen. Schattauer, Stuttgart-New York"},{"key":"70_CR22","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1136\/jnnp.2008.161059","volume":"81","author":"EJ Baldwin","year":"2010","unstructured":"Baldwin EJ, Gibberd FB, Harley C et al (2010) The effectiveness of long-term dietary therapy in the treatment of adult Refsum disease. J Neurol Neurosurg Psychiatry 81:954","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"70_CR23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/jca.21200","volume":"27","author":"D Zolotov","year":"2012","unstructured":"Zolotov D, Wagner S, Kalb K, Bunia J, Heibges A, Klingel R (2012) Long-term strategies for the treatment of Refsum\u2019s disease using therapeutic apheresis. J Clin Apher 27(2):99\u2013105","journal-title":"J Clin Apher"},{"key":"70_CR24","unstructured":"Percy AK, Wanders RJA, Peterson MC, Firth HV, Hoppin AG (2014) Peroxisomal disorders. UpToDate 1\u201317"},{"key":"70_CR25","doi-asserted-by":"crossref","unstructured":"M\u00f6sges R, K\u00f6berlein J, Heibges A, Erdtracht B, Klingel R, Lehmacher W (2009) Rheopheresis for idiopathic sudden hearing loss: results from a large prospective, multicenter, randomized, controlled clinical trial. Eur Arch Otorhinolaryngol 266(7):943\u2013953. doi:10.1007\/s00405-008-0823-5","DOI":"10.1007\/s00405-008-0823-5"},{"key":"70_CR26","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1744-9987.2010.00807.x","volume":"14","author":"R Klingel","year":"2010","unstructured":"Klingel R, Fassbender C, Heibges A, Koch F, Nasemann J, Engelmann K, Carl T, Meinke M, Erdtracht B (2010) RheoNet registry analysis of rheopheresis for microcirculatory disorders with a focus on age-related macular degeneration. Ther Apher Dial 14:276\u2013286","journal-title":"Ther Apher Dial"}],"container-title":["Clinical Research in Cardiology Supplements"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11789-015-0070-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11789-015-0070-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11789-015-0070-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T19:15:55Z","timestamp":1553627755000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11789-015-0070-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,17]]},"references-count":26,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["70"],"URL":"https:\/\/doi.org\/10.1007\/s11789-015-0070-4","relation":{},"ISSN":["1861-0706","1861-0714"],"issn-type":[{"value":"1861-0706","type":"print"},{"value":"1861-0714","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,17]]}}}